News

Access and download our newsletters from the Newsletter Archive

 
 

As well as keeping you up to date with the latest developments within the life sciences sector, Bionow members can also post updates to the Bionow News page to promote themselves to over 300 Bionow member organisations and the UK Life Sciences sector.

Whether currently a member or not, keep up to date with all the latest news and events by registering to receive the Bionow newsletter.

Aptamer Group signs two substantial new contracts

Jan 25th 2023
Contracts worth over £500,000 with the potential for downstream milestone and royalty/ licensing payments
Read More

Aptamer Group announce new deals to support novel therapies and improved assays

Dec 5th 2022
Aptamer Group announces a selection of new contract wins where Optimer technology is being explored by partners to offer new strategies for therapeutics and potentially offer improved assay ...
Read More

Honorary Professorship for Aptamer Group CEO

Apr 4th 2022
Aptamer Group’s CEO, Dr Arron Tolley, has been awarded a Visiting Professorship in Biological and Translational Sciences from the Faculty of Health and Medical Sciences, University of Surr...
Read More

Aptamer Group Celebrates its AIM Listing Success

Mar 21st 2022
Aptamer Group celebrated its recent Admission to AIM on Friday evening, with an exclusive party at the Sora Sky bar in the Malmaison hotel, York.
Read More

Admission to AIM and First Day of Dealings

Dec 23rd 2021
Aptamer Group announces admission to trading on AIM
Read More

Aptamer Group and ValitaCell to develop biomanufacturing screening platform

Nov 30th 2021
Aptamer Group and ValitaCell have entered a long-term collaboration with the agreement of commercial terms regarding the development of a next-generation biologic screening platform. The exi...
Read More

Aptamer Group signs material commercial agreement with a life science research c...

Oct 14th 2021
Aptamer Group Ltd, the developer of novel Optimer® binders to enable innovation in the life sciences industry, today announces that it has entered into a large-scale Optimer development and...
Read More

Aptamer Group and BizCom announce collaboration for Optimer distribution and mar...

Sep 28th 2021
Aptamer Group, Ltd. the developer of Optimer® binders to enable innovation in the life science industry, and BizCom Japan, Inc., a Japan-based trading and consultancy company, today announc...
Read More

Aptamer Group and Bio-Works Technologies partner to enable improved solutions fo...

Aug 25th 2021
Aptamer Group Ltd, the developer of custom affinity tools to enable the life science industry through its proprietary Optimer platform, and Bio-Works Technologies AB, the developer and manuf...
Read More

Aptamer Group and WuXi AppTec Research Service Division collaborate to identify ...

Jul 22nd 2021
Aptamer Group Limited, the developer of Optimer™ therapeutics and diagnostics, and WuXi AppTec Research Service Division, an integrated chemistry and biology research platform, today annou...
Read More

Aptamer Group and PinotBio collaborate to develop new therapeutic drug conjugate...

Jun 2nd 2021
Aptamer Group Limited, the developer of Optimer™ Therapeutics, and PinotBio (Gyeonggi-do, Korea), a clinical-stage oncology-focused biotechnology company, today announces that they have en...
Read More

Aptamer Group and Mologic enter commercial partnership to develop aptamer-based ...

Mar 17th 2021
Aptamer Group and Mologic extend collaboration to CE mark Aptamer Group's SARS-CoV-2 rapid antigen test
Read More

Search Site

  Latest Jobs

Sign up to our Newsletter

Our Valued Sponsors & Partners